Table 2.
Overall patients (n = 503) | P value | |||
---|---|---|---|---|
No NeOAF (n = 263) | NeOAF to SR (n = 165) | NeOAF to AF (n = 75) | ||
Laboratory | ||||
WBC (×103/L) | 13.47 ± 8.73 | 13.43 ± 7.23 | 15.39 ± 11.73 | 0.22 |
CRP (mmol/L) | 12.8 ± 10.9 | 10.0 ± 9.9† | 11.2 ± 8.5 | 0.02 |
Na+ (mmol/L) | 135.6 ± 8.5 | 135.7 ± 10.1 | 136.7 ± 7.8 | 0.64 |
K+ (mmol/L) | 4.1 ± 1.0 | 4.2 ± 1.0 | 4.1 ± 0.9 | 0.46 |
Free Ca2+ (mmol/L) | 4.23 ± 0.31 | 4.35 ± 0.46 | 4.17 ± 0.68 | 0.46 |
Albumin (g/dL) | 2.7 ± 0.6 | 2.7 ± 0.6 | 2.6 ± 0.6 | 0.37 |
BNP (pg/ml) | 918.6 ± 1152.2 | 1131.3 ± 1325.6 | 1102.4 ± 1418.1 | 0.58 |
Tr-I (ng/ml) | 1.09 ± 5.92 | 1.98 ± 5.95 | 3.71 ± 13.42a | 0.04 |
Echocardiography | ||||
LAD (mm) | 36.5 ± 7.4 | 38.4 ± 7.2† | 40.5 ± 7.2a | <0.01 |
LVEDD (mm3) | 45.7 ± 8.0 | 46.1 ± 7.7 | 46.6 ± 7.5 | 0.73 |
LVESD (mm3) | 30.3 ± 8.0 | 30.9 ± 7.3 | 32.3 ± 8.4 | 0.22 |
LVEF < 50%, n (%) | 31 (13.7) | 29 (18.2) | 18 (27.7)† | 0.03 |
NeOAF new-onset atrial fibrillation, AF atrial fibrillation, SR sinus rhythm, WBC white blood cell count, CRP C-reactive protein, BNP B-type natriuretic peptide, Tr-I troponin I, LAD left atrium diameter, LVEDD left ventricular end diastolic diameter, LVESD left ventricular end systolic diameter, LVEF left ventricular ejection fraction. a P < 0.05 vs. no NeOAF